U.S. Code · Título 42
Activities relating to cardiomyopathy
42 U.S.C. § 244b
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
Report on CDC national cardiomyopathy activities
In general
Not later than 18 months after December 23, 2024, the Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall submit to Congress a report on findings generated from existing activities conducted by the Centers for Disease Control and Prevention to improve the understanding of the prevalence and epidemiology of cardiomyopathy across the lifespan, from birth to adulthood, with particular interest in the following:
Public access
Subject to paragraph (3), the report submitted under this subsection shall be made available to the public.
Privacy protections
The Secretary shall ensure that this subsection is carried out in a manner that complies with all applicable privacy laws under Federal and State law.
Improving risk assessments for individuals with cardiomyopathy
In general
The Secretary shall develop and make publicly available a cardiomyopathy risk assessment for health care providers and individuals. Such risk assessment shall, at a minimum, include the following:
Stakeholder input
In carrying out paragraph (1), the Director of the Centers for Disease Control and Prevention shall seek input from external stakeholders including—
Definition
In this section, the term “cardiomyopathy” has the meaning given to such term in section 244a of this title.
(July 1, 1944, ch. 373, title III, § 312B, as added Pub. L. 118–176, § 2(a), Dec. 23, 2024, 138 Stat. 2607.)